HTS heading 2922
42 exclusion requests, from 18 distinct filers, across the 2018–20 tranches.
42
requests filed
2
granted
4.8% (95% CI 1.3–15.8%, n=42)
grant rate, all filers
Cross-tranche — see caution below
4.8% (95% CI 1.3–15.8%, n=42)
excluding mass filers
42 requests
By tranche
| Tranche | Requests | Granted | Denied | Grant rate |
|---|---|---|---|---|
| List 3 | 42 | 2 | 40 | 4.8% (95% CI 1.3–15.8%, n=42) |
The cross-tranche rate above blends processes. Where this heading appears in more than one tranche, use the per-tranche rows. Where a rate reads “n too small”, fewer than 20 requests were decided and no rate is published for it.
Products filed under this heading
Product titles as they appear on the public docket, unedited. These are examples, not a complete list, and their presence here says nothing about their outcome.
- Bupropion Hydrochloride
- Para Amino Phenol
- Gabapentin USP
- 4-amino-2-hydroxytoluene
- m-aminophenol
- 4-Methoxy-2-Methyl Diphenyl Amine (DPA)
- Aktiplast PP (A00035)
- Alpha Lipoic Acid